(CAMBRIDGE, Mass.)Alkermes Inc. announced Monday it has regained full commercialization rights in the United States for the alcoholism treatment Vivitrol. The biotechnology company said it has ended...READ MORE

(NEW YORK)Shares of biotechnology company Amylin Pharmaceuticals Inc. jumped Monday as IMS Health data showed an uptick in prescriptions of its beleaguered diabetes treatment Byetta.READ MORE

(SAN DIEGO)Drugmaker Amylin Pharmaceuticals Inc. said Monday it will eliminate 340 jobs, or a quarter of its San Diego work force, in a move it said will cut its operating expenses by more th...READ MORE

(NEW YORK)Shares of biotechnology company Amylin Pharmaceuticals Inc. plunged to a new low point Tuesday, after the company said its regulatory approval timeline could be delayed for the muc...READ MORE

(NEW YORK)New medical industry treatment guidelines could give Eli Lilly & Co.'s and Amylin Pharmaceuticals Inc.'s diabetes drug Byetta a boost as it continues to deal with safety concerns o...READ MORE

(NEW YORK)Amylin Pharmaceuticals Inc. and Eli Lilly and Co., which are developing a weekly form of the diabetes drug Byetta, said Tuesday they have reached a supply agreement in which Lilly ...READ MORE

(CAMBRIDGE, Mass.)Alkermes Inc. said Thursday a long-acting version of its schizophrenia drug Risperdal has been approved for arm injection by U.S. health regulators. The approval by the Food and Dr...READ MORE